Follow-up of clinical stage I testicular cancer patients: Cost and risk benefit considerations

International Journal of Urology

Volumn 9, Issue 3, 2002, Pages 154-160

  Kakehi, Yoshiyuki ^a,c   Kamoto, Toshiyuki ^a   Kawakita, Mutsushi ^b   Ogawa, Osamu ^a  

^a KYOTO UNIVERSITY   (Japan)

^b KANSAI MEDICAL UNIVERSITY   (Japan)

^c KAGAWA UNIVERSITY   (Japan)

Author keywords

Cost and risk benefit; Follow up protocol; Stage I testis cancer

Indexed keywords

CARBOPLATIN;

ARTICLE; CANCER ADJUVANT THERAPY; CANCER GROWTH; CANCER RECURRENCE; CANCER STAGING; COST EFFECTIVENESS ANALYSIS; FOLLOW UP; GERM CELL TUMOR; HUMAN; ORCHIECTOMY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; RISK BENEFIT ANALYSIS; TESTIS CARCINOMA; THORAX RADIOGRAPHY;

CARBOPLATIN; CHEMOTHERAPY, ADJUVANT; COST-BENEFIT ANALYSIS; FOLLOW-UP STUDIES; GERMINOMA; HUMANS; MALE; NEOPLASM STAGING; ORCHIECTOMY; RISK ASSESSMENT; TESTICULAR NEOPLASMS; TREATMENT OUTCOME;

EID: 0036093534     PISSN: 09198172     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1442-2042.2002.00440.x     Document Type: Article

References (27)

1. Cost-effectiveness of post-treatment surveillance after radiation therapy for early stage seminoma
2. The use of a Markov process to simulate and asserss follow-up policies for patients with malignant disease: Surveillance for stage I non-seminomatous tumors of the testis
3. Cost-effective strategies for the follow-up of patients with germ cell tumors
4. Adjuvant radiation versus observation: A cost analysis of alternative management schemes in early-stage testicular seminoma
5. Cost and risk benefit in the management of clinical stage II nonseminomatous testicular tumors
6. Retroperitoneal lymphadenectomy for clinical stage A testis cancer (1965-89): Modifications of technique and impact on ejaculation
7. Treatment of stage I testicular tumors
8. A surveillance study of clinical stage I nonseminomatous germ cell tumors of the testis: 10-Year followup
9. Histopathology in the prediction of relapse of patients with stage I testicular teratoma treated by orchidectomy alone
10. Detection of recurrence in patients with clinical stage I nonseminomatous germ cell tumors and consequences for further follow-up: A single center 10-year experience
11. Late relapse of testicular cancer
12. Results of the surveillance policy of stage I nonseminomatous germ cell testicular tumours
13. Medical Research Council prospective study of surveillance for stage I testicular teratoma
14. Progression detection of stage I nonseminomatous testis cancer on surveillance: Implications for the follow-up protocol
15. Bilateral testicular tumor
16. Cost and risk benefit considerations in the management of clinical stage I non-seminomatous testicular tumors
17. Surveillance versus nerve-sparing retroperitoneal lymphadenectomy in stage I nonseminomatous germ cell tumors
18. Surveillance study for clinical stage I testicular seminomas and nonseminomatous germ cell tumors
19. Stage I testicular seminoma: Results of adjuvant irradiation and surveillance
20. Stage I testicular seminoma: Rationale for postorchiectomy radiation therapy
21. Optimal planning target Volume for stage I testicular seminoma: A Medical Research Council randomized trial
22. Second malignancies following testicular cancer, ovarian cancer and Hodgkins disease: An international collaborative study among cancer registries
23. Carboplatin-monotherapie bei seminomen im stadium I
24. Pilot studies of 2 and 1 course carboplatin as adjuvant for stage I seminoma: Should it be tested in a randomized trial against radiotherapy?
25. Phase II study: Adjuvant single-agent carboplatin therapy for clinical stage I seminoma
26. Carboplatin monotherapy in clinical stage I of seminoma. An acceptable alternative?
27. Adjuvant treatment of clinical stage I seminoma: Is a single course of carboplatin sufficient?